SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

被引：0
|
作者：
Schlitt, H. J. [1 ]
Nashan, B. [1 ]
Schemmer, P. [1 ]
Pascher, A. [1 ]
Klein, C. G. [1 ]
Neumann, U. [1 ]
Kroeger, I. [2 ]
Wimmer, P. [2 ]
Braun, F. [1 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
V079
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [42] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update
    Filipponi, F.
    De Carlis, L.
    Metselaar, H. J.
    Nevens, F.
    Saliba, F.
    Junge, G.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S132 - S133
  • [43] Outcomes on Allograft Function after 12 Months with Everolimus Plus either Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA Regimen in De Novo Renal Transplant Recipients: The Athena Study
    Schenker, Peter
    Sommerer, Claudia
    Suwelack, Barbara
    Dragun, Duska
    Hauser, Ingeborg A.
    Witzke, Oliver
    Hugo, Christian
    Kamar, Nassim
    Merville, Pierre
    Junge, Martina
    Thaiss, Friedrich
    Nashan, Bjoern
    TRANSPLANTATION, 2018, 102 : S280 - S280
  • [44] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients.
    Peddi, V.
    Qazi, Y.
    Shaffer, D.
    Luan, F.
    Shihab, F.
    Tomlanovich, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [45] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Lopez, Patricia
    Levy, Gary
    Jeng, Long-Bin
    Suh, Kyung Suk
    Joo, Dong Jin
    Lee, Sung Gyu
    Lee, Wei-Chen
    Chen, Chao-Long
    Soin, Arvinder Singh
    Joh, Jae Won
    Yoshizumi, Tomoharu
    Grant, David
    Martzloff, El-Djouher
    Sips, Carole
    Wang, Zailong
    TRANSPLANT INTERNATIONAL, 2015, 28 : 459 - 459
  • [46] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Settmacher, U.
    Braun, F.
    Sips, C.
    Dong, G.
    Kroeger, I.
    Sanchez, J. Aguilar
    TRANSPLANT INTERNATIONAL, 2015, 28 : 32 - 32
  • [47] Everolimus with Reduced CsA vs MMF with Standard CsA Exposure in De Novo Heart Transplant Recipients: 12 Month Efficacy and Safety Analysis
    Eisen, H.
    Pauly, D.
    Starling, R.
    Lehmkuhl, H.
    Ross, H.
    Kfoury, A.
    Wang, S.
    Cantin, B.
    Van Bakel, A.
    Zuckermann, A.
    Lopez, P.
    Dong, G.
    Panis, C.
    Jiang, H.
    Cornu-Artis, C.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S25 - S26
  • [48] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Suh, Kyung-Suk
    Joo, Dong Jin
    Uemoto, Shinji
    Joh, Jaewon
    Yoshizumi, Tomoharu
    Yang, Horng-Ren
    Song, Gi-Won
    Lopez, Patricia
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (06) : 1435 - 1446
  • [49] 12 MONTHS OUTCOMES ON ALLOGRAFT FUNCTION WITH EVEROLIMUS-CNI VS TACROLIMUS-MPA REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS: THE ATHENA STUDY
    Merville, P.
    Kamar, N.
    Dragun, D.
    Sommerer, C.
    Suwelack, B.
    Schenker, P.
    Hauser, I. A.
    Witzke, O.
    Hugo, C.
    Junge, M.
    Thaiss, F.
    Nashan, B.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 15 - 15
  • [50] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
12345